287 related articles for article (PubMed ID: 20501652)
1. Fenofibrate increases very low density lipoprotein triglyceride production despite reducing plasma triglyceride levels in APOE*3-Leiden.CETP mice.
Bijland S; Pieterman EJ; Maas AC; van der Hoorn JW; van Erk MJ; van Klinken JB; Havekes LM; van Dijk KW; Princen HM; Rensen PC
J Biol Chem; 2010 Aug; 285(33):25168-75. PubMed ID: 20501652
[TBL] [Abstract][Full Text] [Related]
2. ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis.
Schaap FG; Rensen PC; Voshol PJ; Vrins C; van der Vliet HN; Chamuleau RA; Havekes LM; Groen AK; van Dijk KW
J Biol Chem; 2004 Jul; 279(27):27941-7. PubMed ID: 15090553
[TBL] [Abstract][Full Text] [Related]
3. Effect of fenofibrate and niacin on intrahepatic triglyceride content, very low-density lipoprotein kinetics, and insulin action in obese subjects with nonalcoholic fatty liver disease.
Fabbrini E; Mohammed BS; Korenblat KM; Magkos F; McCrea J; Patterson BW; Klein S
J Clin Endocrinol Metab; 2010 Jun; 95(6):2727-35. PubMed ID: 20371660
[TBL] [Abstract][Full Text] [Related]
4. Metformin lowers plasma triglycerides by promoting VLDL-triglyceride clearance by brown adipose tissue in mice.
Geerling JJ; Boon MR; van der Zon GC; van den Berg SA; van den Hoek AM; Lombès M; Princen HM; Havekes LM; Rensen PC; Guigas B
Diabetes; 2014 Mar; 63(3):880-91. PubMed ID: 24270984
[TBL] [Abstract][Full Text] [Related]
5. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
[TBL] [Abstract][Full Text] [Related]
6. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review.
Oscarsson J; Hurt-Camejo E
Lipids Health Dis; 2017 Aug; 16(1):149. PubMed ID: 28797250
[TBL] [Abstract][Full Text] [Related]
7. Bexarotene induces dyslipidemia by increased very low-density lipoprotein production and cholesteryl ester transfer protein-mediated reduction of high-density lipoprotein.
de Vries-van der Weij J; de Haan W; Hu L; Kuif M; Oei HL; van der Hoorn JW; Havekes LM; Princen HM; Romijn JA; Smit JW; Rensen PC
Endocrinology; 2009 May; 150(5):2368-75. PubMed ID: 19147676
[TBL] [Abstract][Full Text] [Related]
8. Perfluoroalkyl sulfonates cause alkyl chain length-dependent hepatic steatosis and hypolipidemia mainly by impairing lipoprotein production in APOE*3-Leiden CETP mice.
Bijland S; Rensen PC; Pieterman EJ; Maas AC; van der Hoorn JW; van Erk MJ; Havekes LM; Willems van Dijk K; Chang SC; Ehresman DJ; Butenhoff JL; Princen HM
Toxicol Sci; 2011 Sep; 123(1):290-303. PubMed ID: 21705711
[TBL] [Abstract][Full Text] [Related]
9. Preferential reduction of very low density lipoprotein-1 particle number by fenofibrate in type IIB hyperlipidemia: consequences for lipid accumulation in human monocyte-derived macrophages.
Milosavljevic D; Griglio S; Le Naour G; Chapman MJ
Atherosclerosis; 2001 Mar; 155(1):251-60. PubMed ID: 11223449
[TBL] [Abstract][Full Text] [Related]
10. Dose Effects of Ammonium Perfluorooctanoate on Lipoprotein Metabolism in APOE*3-Leiden.CETP Mice.
Pouwer MG; Pieterman EJ; Chang SC; Olsen GW; Caspers MPM; Verschuren L; Jukema JW; Princen HMG
Toxicol Sci; 2019 Apr; 168(2):519-534. PubMed ID: 30657992
[TBL] [Abstract][Full Text] [Related]
11. Tissue-specific postprandial clearance is the major determinant of PPARgamma-induced triglyceride lowering in the rat.
Laplante M; Festuccia WT; Soucy G; Blanchard PG; Renaud A; Berger JP; Olivecrona G; Deshaies Y
Am J Physiol Regul Integr Comp Physiol; 2009 Jan; 296(1):R57-66. PubMed ID: 18971352
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E participates in the regulation of very low density lipoprotein-triglyceride secretion by the liver.
Mensenkamp AR; Jong MC; van Goor H; van Luyn MJ; Bloks V; Havinga R; Voshol PJ; Hofker MH; van Dijk KW; Havekes LM; Kuipers F
J Biol Chem; 1999 Dec; 274(50):35711-8. PubMed ID: 10585451
[TBL] [Abstract][Full Text] [Related]
13. Markedly increased secretion of VLDL triglycerides induced by gene transfer of apolipoprotein E isoforms in apoE-deficient mice.
Tsukamoto K; Maugeais C; Glick JM; Rader DJ
J Lipid Res; 2000 Feb; 41(2):253-9. PubMed ID: 10681409
[TBL] [Abstract][Full Text] [Related]
14. The Hyplip2 locus causes hypertriglyceridemia by decreased clearance of triglycerides.
Moen CJ; Tholens AP; Voshol PJ; de Haan W; Havekes LM; Gargalovic P; Lusis AJ; van Dyk KW; Frants RR; Hofker MH; Rensen PC
J Lipid Res; 2007 Oct; 48(10):2182-92. PubMed ID: 17609525
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor-alpha selective ligand reduces adiposity, improves insulin sensitivity and inhibits atherosclerosis in LDL receptor-deficient mice.
Srivastava RA; Jahagirdar R; Azhar S; Sharma S; Bisgaier CL
Mol Cell Biochem; 2006 Apr; 285(1-2):35-50. PubMed ID: 16477380
[TBL] [Abstract][Full Text] [Related]
16. Paradoxical exacerbation of combined hyperlipidemia in human apolipoprotein A-II transgenic mice treated with fenofibrate.
Ribas V; Palomer X; Roglans N; Rotllan N; Fievet C; Tailleux A; Julve J; Laguna JC; Blanco-Vaca F; Escolà-Gil JC
Biochim Biophys Acta; 2005 Dec; 1737(2-3):130-7. PubMed ID: 16226489
[TBL] [Abstract][Full Text] [Related]
17. Fenofibrate increases HDL-cholesterol by reducing cholesteryl ester transfer protein expression.
van der Hoogt CC; de Haan W; Westerterp M; Hoekstra M; Dallinga-Thie GM; Romijn JA; Princen HM; Jukema JW; Havekes LM; Rensen PC
J Lipid Res; 2007 Aug; 48(8):1763-71. PubMed ID: 17525476
[TBL] [Abstract][Full Text] [Related]
18. Cholesteryl ester transfer protein (CETP) increases postprandial triglyceridaemia and delays triacylglycerol plasma clearance in transgenic mice.
Salerno AG; Patrício PR; Berti JA; Oliveira HC
Biochem J; 2009 May; 419(3):629-34. PubMed ID: 19191759
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein C-III deficiency accelerates triglyceride hydrolysis by lipoprotein lipase in wild-type and apoE knockout mice.
Jong MC; Rensen PC; Dahlmans VE; van der Boom H; van Berkel TJ; Havekes LM
J Lipid Res; 2001 Oct; 42(10):1578-85. PubMed ID: 11590213
[TBL] [Abstract][Full Text] [Related]
20. Ritonavir impairs lipoprotein lipase-mediated lipolysis and decreases uptake of fatty acids in adipose tissue.
den Boer MA; Berbée JF; Reiss P; van der Valk M; Voshol PJ; Kuipers F; Havekes LM; Rensen PC; Romijn JA
Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):124-9. PubMed ID: 16269669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
